TITAN BIOTECH
|
TITAN BIOTECH Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 26.06 | 30.07 | 30.06 | 26.24 | 36.71 |
| CEPS(Rs) | 27.16 | 32.67 | 28.59 | 29.11 | 41.05 |
| DPS(Rs) | 2.00 | 2.00 | 1.80 | 1.50 | 1.50 |
| Book NAV/Share(Rs) | 185.64 | 161.49 | 133.00 | 104.36 | 83.21 |
| Tax Rate(%) | 25.02 | 24.95 | 25.22 | 25.15 | 25.76 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 16.25 | 20.89 | 20.50 | 25.31 | 32.47 |
| EBIT Margin(%) | 16.09 | 19.93 | 20.04 | 24.15 | 31.24 |
| Pre Tax Margin(%) | 15.58 | 19.22 | 19.53 | 23.45 | 30.02 |
| PAT Margin (%) | 11.68 | 14.42 | 14.60 | 17.55 | 22.29 |
| Cash Profit Margin (%) | 14.34 | 16.45 | 16.41 | 19.47 | 23.85 |
| Performance Ratios | |||||
| ROA(%) | 10.58 | 15.44 | 16.37 | 19.16 | 33.50 |
| ROE(%) | 12.74 | 19.45 | 21.44 | 27.98 | 58.74 |
| ROCE(%) | 17.00 | 25.39 | 27.40 | 33.74 | 60.80 |
| Asset Turnover(x) | 0.91 | 1.07 | 1.12 | 1.09 | 1.50 |
| Sales/Fixed Asset(x) | 2.06 | 2.65 | 2.84 | 2.62 | 3.29 |
| Working Capital/Sales(x) | 2.55 | 3.09 | 3.00 | 2.64 | 3.60 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.49 | 0.38 | 0.35 | 0.38 | 0.30 |
| Receivable days | 43.71 | 44.12 | 47.36 | 50.91 | 38.45 |
| Inventory Days | 112.33 | 90.92 | 89.79 | 99.29 | 77.64 |
| Payable days | 21.58 | 21.53 | 25.39 | 24.97 | 23.89 |
| Valuation Parameters | |||||
| PER(x) | 16.18 | 17.56 | 6.55 | 9.99 | 5.05 |
| PCE(x) | 15.52 | 16.17 | 6.89 | 9.00 | 4.52 |
| Price/Book(x) | 2.27 | 3.27 | 1.48 | 2.51 | 2.23 |
| Yield(%) | 0.47 | 0.38 | 0.91 | 0.57 | 0.81 |
| EV/Net Sales(x) | 2.20 | 2.68 | 1.14 | 1.76 | 1.14 |
| EV/Core EBITDA(x) | 11.76 | 12.22 | 5.24 | 6.75 | 3.45 |
| EV/EBIT(x) | 13.70 | 13.47 | 5.71 | 7.28 | 3.65 |
| EV/CE(x) | 2.22 | 3.13 | 1.41 | 2.32 | 1.46 |
| M Cap / Sales | 2.23 | 2.66 | 1.13 | 1.75 | 1.08 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -4.65 | 13.94 | 16.55 | -13.14 | 79.05 |
| Core EBITDA Growth(%) | -18.57 | 14.52 | -2.32 | -31.43 | 237.04 |
| EBIT Growth(%) | -23.03 | 13.29 | -3.28 | -32.84 | 248.46 |
| PAT Growth(%) | -22.79 | 12.55 | -3.04 | -31.61 | 304.54 |
| EPS Growth(%) | -13.36 | 0.04 | 14.57 | -28.52 | 329.32 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | 0.05 | 0.06 | 0.09 | 0.21 |
| Current Ratio(x) | 3.59 | 2.94 | 2.74 | 2.95 | 2.33 |
| Quick Ratio(x) | 1.45 | 1.27 | 1.43 | 1.51 | 1.24 |
| Interest Cover(x) | 31.39 | 27.95 | 38.69 | 34.22 | 25.72 |
| Total Debt/Mcap(x) | 0.01 | 0.02 | 0.04 | 0.03 | 0.09 |
Compare Financial Ratios of peers of TITAN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TITAN BIOTECH | ₹967.9 Cr | -7.8% | 17.1% | 21.2% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹153,349.0 Cr | -2.3% | 1.2% | -3.7% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹126,972.0 Cr | -0.1% | -1.3% | 24.3% | Stock Analytics | |
| SRF | ₹91,457.4 Cr | -2.6% | 6.2% | 35% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹40,667.0 Cr | -0.3% | -4.2% | -22.4% | Stock Analytics | |
| GODREJ INDUSTRIES | ₹36,592.0 Cr | 0.2% | -8% | 8.1% | Stock Analytics | |
TITAN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TITAN BIOTECH | -7.8% |
17.1% |
21.2% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses
